Jenkem Technology Co Ltd (688356) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jenkem Technology Co Ltd (688356) has a cash flow conversion efficiency ratio of -0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-16.46 Million ≈ $-2.41 Million USD) by net assets (CN¥1.30 Billion ≈ $189.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 688356 company net worth for the company's overall valuation and market capitalisation.
Jenkem Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Jenkem Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Jenkem Technology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jenkem Technology Co Ltd ranked by their cash flow conversion efficiency. Explore Jenkem Technology Co Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aussie Broadband Ltd
AU:ABB
|
0.052x |
|
Dynavox Group
ST:DYVOX
|
0.172x |
|
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
|
0.072x |
|
Liberty Gold Corp
TO:LGD
|
-0.174x |
|
Minerals 260 Ltd
AU:MI6
|
-0.038x |
|
Sunrise Group Co Ltd
SHE:002752
|
0.004x |
|
Jiangsu Sanfangxiang Industry Co Ltd
SHG:600370
|
0.168x |
|
Luzerner Kantonalbank AG
LSE:0QNU
|
0.004x |
Annual Cash Flow Conversion Efficiency for Jenkem Technology Co Ltd (2016–2024)
The table below shows the annual cash flow conversion efficiency of Jenkem Technology Co Ltd from 2016 to 2024. View Jenkem Technology Co Ltd stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.27 Billion ≈ $185.37 Million |
CN¥120.18 Million ≈ $17.59 Million |
0.095x | +1.37% |
| 2023-12-31 | CN¥1.28 Billion ≈ $187.32 Million |
CN¥119.81 Million ≈ $17.53 Million |
0.094x | -38.33% |
| 2022-12-31 | CN¥1.22 Billion ≈ $179.22 Million |
CN¥185.86 Million ≈ $27.20 Million |
0.152x | +34.97% |
| 2021-12-31 | CN¥1.05 Billion ≈ $153.89 Million |
CN¥118.23 Million ≈ $17.30 Million |
0.112x | +23.07% |
| 2020-12-31 | CN¥856.24 Million ≈ $125.30 Million |
CN¥78.22 Million ≈ $11.45 Million |
0.091x | -60.53% |
| 2019-12-31 | CN¥220.35 Million ≈ $32.24 Million |
CN¥51.00 Million ≈ $7.46 Million |
0.231x | +15.95% |
| 2018-12-31 | CN¥168.70 Million ≈ $24.69 Million |
CN¥33.68 Million ≈ $4.93 Million |
0.200x | +30.63% |
| 2017-12-31 | CN¥139.70 Million ≈ $20.44 Million |
CN¥21.35 Million ≈ $3.12 Million |
0.153x | +25.56% |
| 2016-12-31 | CN¥122.81 Million ≈ $17.97 Million |
CN¥14.95 Million ≈ $2.19 Million |
0.122x | -- |
About Jenkem Technology Co Ltd
Jenkem Technology Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of medical and pharmaceutical polyethylene glycol derivative (PEG) products in China and internationally. The company offers high molecular weight polyethylene glycol derivatives comprising branched, methoxylated, bifunctionalized, heterofunctionalized disubstituted, multi-arm, … Read more